BIO-key International
BKYI
12 hedge funds and large institutions have $2.06M invested in BIO-key International in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
3% less capital invested
Capital invested by funds: $2.11M → $2.06M (-$53K)
8% less funds holding
Funds holding: 13 → 12 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
51% less call options, than puts
Call options by funds: $954K | Put options by funds: $1.94M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$194K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$50.1K |
| 3 |
Two Sigma Advisers
New York
|
+$36.6K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$10K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$7.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$74K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$46K |
| 3 |
Goldman Sachs
New York
|
-$46K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$41.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.4K |
BKYI Hedge Fund Activity: Q3 2021 in Review
12 of the 5,727 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2021, worth a combined $2.06M — down 2.5% from $2.11M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BKYI and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $194K. The largest seller was Virtu Financial, exiting entirely with an estimated $74K sold.
- 12 institutional investors held BIO-key International (BKYI) as of Q3 2021, down from 13 in Q2 2021.
- Funds reported $2.06M of BIO-key International stock for Q3 2021, down 2.5% quarter-over-quarter.
- 3 funds opened new BIO-key International positions in Q3 2021 and 4 closed out, a net change of -1 holder.
- The largest BIO-key International buyer in Q3 2021 was Two Sigma Investments, an estimated $194K added.
- The largest BIO-key International seller in Q3 2021 was Virtu Financial, an estimated $74K sold.
Based on aggregated 13F filings for Q3 2021.